Zivo Bioscience Inc Revenue Growth Rates (ZIVO), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Zivo Bioscience Inc   (ZIVO)
 

ZIVO's Revenue Growth by Quarter and Year

Zivo Bioscience Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ZIVO Revenue (in millions $) FY 2025 FY 2024 FY 2023 FY 2022
4th Quarter December -
3rd Quarter September 0.07
2nd Quarter June 0.05
1st Quarter March 0.00
FY 0.12

ZIVOs Annual Revenue
Zivo Bioscience Inc 's Revenue in the fiscal year 2024 $ 0.16 millions
Zivo Bioscience Inc 's Revenue in the fiscal year 2023 $ 0.03 millions
Zivo Bioscience Inc 's Revenue in the fiscal year 2022 $ 0.00 millions
Zivo Bioscience Inc 's Revenue in the fiscal year 2021 $ 0.00 millions
Zivo Bioscience Inc 's Revenue in the fiscal year 2020 $ 0.02 millions




ZIVO Revenue third quarter 2025 Y/Y Growth Comment
Zivo Bioscience Inc achieved in the third quarter 2025, above Company average Revenue surge of 118.75% year on year, to $ 0.07 millions.

Looking into third quarter 2025 results within Biotechnology & Pharmaceuticals industry 10 other companies have achieved higher Revenue growth. While Zivo Bioscience Inc ' s Revenue doubling of 118.75% ranks overall at the positon no. 199 in the third quarter 2025.


ZIVO Revenue ( Y/Y Growth %) 2025
 2024 2023 2022
4th Quarter December - 800 % - -
3rd Quarter September 118.75 % 200 % - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY   - 700 % - -

Financial Statements
Zivo Bioscience Inc 's third quarter 2025 Revenue $ 0.07 millions ZIVO's Income Statement
Zivo Bioscience Inc 's third quarter 2024 Revenue $ 0.03 millions Quarterly ZIVO's Income Statement


ZIVO Revenue (Quarter on Quarter Growth %)

 2025
 2024 2023 2022
4th Quarter December - 200 % 0 % -
3rd Quarter September 31.25 % - - -
2nd Quarter June - - - -
1st Quarter March - 300 % - -
FY (Year on Year)   - 700 % - -


Back to ZIVO Growth rate Comparisons >> Back to ZIVO Growth rate Comparisons >>


Revenue third quarter 2025 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #11
Healthcare Sector #55
Overall #199

Revenue Y/Y Growth Statistics
High Average Low
662.71 % 30.71 % -100 %
(Mar 31 2024)   (Jun 30 2024)
Revenue third quarter 2025 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #11
Healthcare Sector #55
Overall #199
Revenue Y/Y Growth Statistics
High Average Low
662.71 % 30.71 % -100 %
(Mar 31 2024)   (Jun 30 2024)

Revenue by Quarter for the Fiscal Years 2022, 2023, 2024, 2025

Zivo Bioscience Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
202.71 % 9.21 % -100 %
(Mar 31 2024)  


ZIVO's III. Quarter Q/Q Revenue Comment
Zivo Bioscience Inc achieved in the III. Quarter 2025 above company average sequential Revenue jump of 31.25%, to $ 0.07 millions, from $0.05 millions in the second quarter.
ZIVO is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Biotechnology & Pharmaceuticals industry 9 other companies have achieved higher Revenue quarter on quarter growth. While Zivo Bioscience Inc 's Revenue growth quarter on quarter, overall rank is 341.


Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #10
Healthcare Sector #79
Overall #341
Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #10
Healthcare Sector #79
Overall #341
Revenue Q/Q Growth Statistics
High Average Low
202.71 % 9.21 % -100 %
(Mar 31 2024)  


ZIVO's III. Quarter Q/Q Revenue Comment
Zivo Bioscience Inc achieved in the III. Quarter 2025 above company average sequential Revenue jump of 31.25%, to $ 0.07 millions, from $0.05 millions in the second quarter.
ZIVO is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Biotechnology & Pharmaceuticals industry 9 other companies have achieved higher Revenue quarter on quarter growth. While Zivo Bioscience Inc 's Revenue growth quarter on quarter, overall rank is 341.


Zivo Bioscience Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)		 12 Months Ending
(Mar 31 2025)		 12 Months Ending
(Dec 31 2024)		 12 Months Ending
(Sep 30 2024)
Cumulative Revenue 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) - - - - -
Seq. Revenue Growth (TTM) Overall Ranking # # # # #


Cumulative Revenue growth Comment
In the Sep 30 2025 period, Zivo Bioscience Inc 's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Zivo Bioscience Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
 0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Revenue growth Comment
In the Sep 30 2025 period, Zivo Bioscience Inc 's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Zivo Bioscience Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Revenue Growth
Biotechnology & Pharmaceuticals Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ZIVO's Revenue Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue jump for the quarter ending Sep 30 2025 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2025
Precigen Inc 206.61%$ 206.611 millions
Phathom Pharmaceuticals Inc 202.74%$ 202.740 millions
Ss Innovations International Inc192.47%$ 192.472 millions
Nuo Therapeutics Inc 178.23%$ 178.230 millions
Seastar Medical Holding Corp169.12%$ 169.118 millions
Innovative Eyewear Inc 163.46%$ 163.458 millions
Travere Therapeutics Inc 162.11%$ 162.105 millions
Dbv Technologies S a 158.77%$ 158.769 millions
Anaptysbio Inc 154.26%$ 154.256 millions
Alnylam Pharmaceuticals Inc 149.35%$ 149.347 millions
Prothena Corporation Public Limited Company148.97%$ 148.969 millions
Tarsus Pharmaceuticals Inc 146.68%$ 146.679 millions
Tscan Therapeutics Inc 139.37%$ 139.371 millions
Catheter Precision Inc 135.42%$ 135.417 millions
Apellis Pharmaceuticals Inc 132.98%$ 132.982 millions
Insight Molecular Diagnostics Inc 126.09%$ 126.087 millions
Cardiff Lexington Corporation125.63%$ 125.631 millions
Ligand Pharmaceuticals Incorporated122.85%$ 122.846 millions
Arcutis Biotherapeutics Inc 121.69%$ 121.694 millions
Stoke Therapeutics Inc 117.25%$ 117.246 millions
Billiontoone Inc 117.12%$ 117.122 millions
Prelude Therapeutics Inc116.67%$ 116.667 millions
Eton Pharmaceuticals Inc 112.14%$ 112.143 millions
Cannapharmarx Inc 110.34%$ 110.340 millions
Harvard Apparatus Regenerative Technology Inc 108.47%$ 108.475 millions
Zivo Bioscience Inc 108.33%$ 108.333 millions
Neuronetics Inc 106.14%$ 106.144 millions
Abvc Biopharma Inc 104.47%$ 104.469 millions
Adaptive Biotechnologies Corporation102.38%$ 102.375 millions
Elite Pharmaceuticals Inc 98.23%$ 98.231 millions


About Zivo Bioscience Inc Revenue Growth Rates (ZIVO), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Zivo Bioscience Inc (CIK 1101026).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001654954-25-013095
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Zivo Bioscience Inc ’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.